Domestic vaccine for COVID-19 developed within 2 years

The MOHW & the Ministry of Science and ICT jointly operate the government support system this week

Taeho Yoon, the head of the quarantine, the Central Emergency Government Headquarters of the Ministry of Health and Welfare is conducting a regular briefing of COVID-19 at the government building as an online live broadcast

The government will immediately implement measures to support for the development of COVID-19 treatment and vaccines.

 

The goal is to release antibody drugs as early as next year, blood plasma treatment within 2-3 months, and vaccines within 2 years.

 

Tae-ho Yoon, the head of the quarantine, the Central Emergency Government Headquarters of the Ministry of Health and Welfare, today, on the morning of the 14th, said through a press after the video conference of COVID-19 Central Disaster Safety Countermeasures Headquarters.

 

At this meeting, the progress of COVID-19 treatment and vaccine development and future plans were discussed.

 

The government said that it was preparing a government support system to develop anti-corrosive drugs and vaccines to overcome COVID-19.

 

In the case of therapeutic drugs, the government is ▲rapidly supporting drug re-creation clinical trials by expanding the range of use of existing drugs to develop drugs that can be treated within the year, and ▲is pursuing the development of antibody drugs and blood device drugs using confirmed patient’s blood.

 

Antibody drugs are being jointly researched by the Korea National Institute of Health & Celltrion, and are expected to be available as early as next year with the goal of entering clinical trials this year.

 

Blood plasma treatment is also under joint research with a domestic company, and if a large amount of blood is secured, the Central Disaster Safety Countermeasures Headquarters expects to develop a therapeutic agent within 2-3 months.

 

In the field of vaccine development, there is a development gap of about 6 months with the United States, but various platform vaccine researches are under way to develop domestic vaccines in the second half of 2021 or 2022 through public-private cooperation and international cooperation research.

 

Vaccines are synthetic antigen vaccines, nucleic acid (DNA) vaccines, and virus delivery (mRNA) vaccines.

 

The government will continue to ▲streamline the provision of blood for cured people, ▲rationalize the application of regulations such as exemption from institutional IRB ▲expand investment in infectious diseases R&D to discover promising tasks, and study the possibility of virus mutations against resurgence ▲build a platform to discover candidates for AI-based treatment ▲the Public Vaccine Development Center ( Completion of this October), expansion of research infrastructure such as the vaccine commercialization project team ▲support for strengthening international cooperation in infectious disease research.

 

Along with this, the government has a support system for the development of COVID-19 treatment and vaccine development system and is operating immediately.

 

Taeho Yoon, the head of the quarantine said that as mentioned by the President, therapeutic drugs and vaccines are a must to overcome in order to completely overcome COVID-19, and plans to establish the government support system so that treatment and vaccine development can succeed early, and provide policy and institutional intensive support.

 

The Minister of Health and Welfare and the Minister of Science and ICT are co-directors, and the 'Corporate Support Group' for COVID-19 treatment and vaccine development is established.

 

▲Domestic COVID-19 treatment and vaccine development status is checked and ▲Support measures are identified by identifying difficulties in the field.

 

"The government will quickly establish a working group with related ministries and industry, academia, research institutes and hospitals to support the pan-government support group," said Yoon, the head of the quarantine.